Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Details Narrative)

v3.22.1
Intangible Assets (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]    
Amortization of Intangible Assets $ 790,488 $ 795,328
Finite-Lived Intangible Asset, Expected Amortization, Year One $ 788,000  
Finite-Lived Intangible Asset, Useful Life 10 years  
Recognition of deferred tax liability $ 530,611
License Rights [Member] | CoNCERT Pharmaceuticals, Inc [Member]    
Finite-Lived Intangible Assets [Line Items]    
Purchase price 8,000,000  
Transaction cost 1,782  
Recognition of deferred tax liability 3,037,147  
Intangible asset, tax basis $ 1,782